Clinical Trial Update: Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating levosimendan for treating aneurysmal subarachnoid hemorrhage, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Subarachnoid Hemorrhage

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sub-arachnoid Haemorrhage | Phase 2 | Status: RECRUITING